"Clinical Trials"

During the past decade, South Texas Accelerated Research Therapeutics (START) Midwest conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Texas Accelerated Research Therapeutics (START) Midwest" #1 sponsor was "Symphogen A/S" with 3 trials, followed by "Daiichi Sankyo, Inc." with 1 trials sponsored, "Debiopharm International SA" with 1 trials sponsored, "Dicerna Pharmaceuticals, Inc." with 1 trials sponsored and "Epizyme, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Texas Accelerated Research Therapeutics (START) Midwest" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "South Texas Accelerated Research Therapeutics (START) Midwest" are "Solid Tumor" (4 trials), "Lymphoma" (3 trials), "Metastatic Cancer" (3 trials), "Advanced Malignancies" (1 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "South Texas Accelerated Research Therapeutics (START) Midwest" in a lesser frequency.

Most popular intervention types in "South Texas Accelerated Research Therapeutics (START) Midwest" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Sym022" (2 trials), "Sym023" (2 trials), "DCR-MYC" (1 trials), "DS-8273a + nivolumab" (1 trials) and "Debio 0123" (1 trials). Other intervention names were less common.

The vast majority of trials in "South Texas Accelerated Research Therapeutics (START) Midwest" are 7 trials for "All" genders.

Currently, there are NaN active trials in "South Texas Accelerated Research Therapeutics (START) Midwest". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in South Texas Accelerated Research Therapeutics (START) Midwest, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in South Texas Accelerated Research Therapeutics (START) Midwest, 7 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".